EORTC High-Dose Chemotherapy Specific Quality of Life Questionnaire--Korean Version
Kyung Im Kim(Korea University), Jung Mi Oh(Seoul National University), Galina Velikova(University of Leeds), Jae Hyun Kim(Seoul National University), Inho Kim(Seoul National University), Jin Seok Kim(University of Ulsan), Jihyun Kwon, Seonyang Park(Seoul National University), Sung-Soo Yoon, Eun Hee Ji, Jun Ho Jang(Samsung Medical Center)
Cited by 0
Related Papers
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
|Leukemia|2017|356
Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier
|Journal of Controlled Release|1998|337